Considerations for prescribing pharmacotherapy for the treatment of erectile dysfunction
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1851365
Abstract: ABSTRACT Introduction: The effectiveness of phosphodiesterase type 5 inhibitors (PDE5i) in treating erectile dysfunction (ED) creates a new field of both medical practice and pharmaceutical manufacturing. Both paved the way for emerging minimally invasive therapies… read more here.
Keywords: treatment; considerations prescribing; erectile dysfunction; prescribing pharmacotherapy ... See more keywords